Anti-Synthetase Syndrome clinical trials at University of California Health

1 research study open to eligible people

RESET-Myositis: an Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy
open to eligible people ages 18-75
RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy
at UC Irvine

Last updated: September 13, 2024